AI Biosciences (AIBI) is an early-stage company that develops rapid, low-cost, and simple-to-use technologies that enable point-of-care (POC) diagnostic with high sensitivity and specificity. In addition, the company develops multi-chamber prefillable syringes for pharmaceutical companies seeking an innovative and convenient delivery system for the reconstitution and administration of lyophilized drugs and vaccines. The firm's technologies include Sample Preparation Cartridge for Molecular Diagnostics, Sequential Injection Syringe for Bioassay Development, and Multi-Chamber Ready-to-fill (Prefilled) Syringes. In 2016, Al Biosciences researchers modified 3D Printers to detect diseases quickly.
